June 22, 2020
"The benefits of the prostate-specific antigen (PSA) test to screen men for prostate cancer may be greater than the harm, say investigators at Weill Cornell Medicine, NewYork-Presbyterian Hospital, University of Washington School of Medicine - WWAMI and the Fred Hutchinson Cancer Research Center.
"The overarching message for the last eight years has been against PSA testing, and its use has declined significantly as a result," said senior author Dr. Jim Hu of WCM and NYP. "At the same time, metastatic prostate cancer in older men has been rising after reaching an all-time low in 2011, as we have documented in a previous study." Read More.
